Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department

NCT03576820 is registered in ClinicalTrials.gov with New York City Health and Hospitals Corporation as lead sponsor.

NCT NCT03576820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03576820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
Lead sponsor
New York City Health and Hospitals Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
October 15, 2018
Completion date
December 31, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine